Doshia Burk
Family · New Castle, INNPI 1982148110
Payments from drug & device makers
Across 121 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$409
- Novo Nordisk$335
- Lilly USA, LLC$266
- Lundbeck LLC$129
- Pfizer$75
- Astellas Pharma US Inc$71
- plus $697 from 23 others
What the payments were for
- Food & beverage$1,983100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,983 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $37,706 |
| JardianceEmpagliflozin | 33 | $27,435 |
| MounjaroTirzepatide | 11 | $19,249 |
| EliquisApixaban | 12 | $15,880 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,826 |
| Omeprazole | 58 | $1,160 |
| Levothyroxine Sodium | 54 | $1,029 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $1,013 |
| Ventolin HfaAlbuterol Sulfate | 16 | $997 |
| Doxepin Hcl | 11 | $964 |
| Atorvastatin Calcium | 57 | $781 |
| Buspirone Hcl | 40 | $697 |
| Gabapentin | 43 | $610 |
| Fluticasone Propionate | 41 | $595 |
| Losartan Potassium | 63 | $552 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $335 | $37,70629 claims |
| Boehringer IngelheimJardiance | $17 | $27,43533 claims |
| Lilly USA, LLCMounjaro | $266 | $19,24911 claims |
| PfizerEliquis | $75 | $15,88012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.
Other family in New Castle
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.